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Abstract Aneurysmal bone cysts (ABCs) are benign bone
tumors consisting of blood-filled cavities lined by connective
tissue septa. Recently, the hypothesis that ABCs are lesions
reactive to local hemodynamics has been challenged after the
discovery of specific recurrent chromosomal abnormalities.
Multiple cases of malignant transformation of ABC into
(osteo)sarcoma have been described, as well as a number of
cases of telangiectatic osteosarcoma which had been mis-
diagnosed as ABC. We herewith document a case of a pelvic
ABC metastatic to the lung, liver, and kidneys. Diagnosis was
confirmedbythepresenceofabreakintheUSP6 gene, which
is pathognomonic for ABC, in a pulmonary metastasis of our
patient. Sarcomatous transformation as an explanation for
this behavior was ruled out by demonstrating diploid DNA




Primary aneurysmal bone cysts (ABC) account for 1–2% of
all primary bone tumors and are usually present in the first
two decades of life [1]. They are composed of blood-filled
spaces separated by connective tissue septa that contain
fibroblasts, osteoclast-type giant cells, and reactive woven
bone [2]. The pathogenesis of primary ABC is still
incompletely understood. In the past, ABCs were consid-
ered reactive lesions caused by altered local hemodynam-
ics. More recently, it was shown that primary ABCs contain
recurrent chromosomal abnormalities [3–13]. This suggests
that primary ABCs are true neoplasms [1]. The differential
diagnosis of primary ABC includes other giant cell-
containing tumors of the bone, particularly giant cell tumor
(GCT) [14]. ABC-like areas can also be seen in association
with other tumors such as chondroblastoma (secondary
ABC). Furthermore, cases of sarcomatous transformation of
ABCs, often occurring after exposure to ionizing radiation,
and of misdiagnosed telangiectatic osteosarcoma have been
recognized. However, even without sarcomatous transfor-
mation, ABC may metastasize as is described in this report.
Clinical history
A 48-year-old woman was referred to our hospital for
treatment of a giant ABC of the left ilium, measuring 27.6×
22.4×15.9 cm (Fig. 1). Her medical history comprised of a
hysterectomy for uterine cervical carcinoma in 1995,
strumectomy for adenomatous thyroid hyperplasia in 1998,
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DOI 10.1007/s00428-009-0845-4and type II diabetes mellitus since 2004. For the ABC, she
had been treated elsewhere with embolization (coiling and
alcoholic zein injection; Ethibloc, Ethicon, Johnson &
Johnson, New Brunswick, NJ, USA) and repeated surgery,
all over a 1-year period. Wide local excision had not been
achieved due to massive hemorrhage during surgical
interventions. In our hospital, preoperative embolization
and percutaneous intralesional alcohol injection were per-
formed and staged resection of the alcohol-treated areas
combined with cryosurgery was attempted. Furthermore, off-
label systemic treatment with the monoclonal antivascular
endothelial growth factor (VEGF) antibody bevacizumab
(Avastin; Roche, Basel, Switzerland; Genentech, South San
Francisco, California, USA) 10 mg/kg administered intrave-
nously every other week was applied to reduce bleeding
tendency. The latter was based on the reports by Kumta et al.
and Shinde et al. showing VEGF positivity in 100% and
50% of primary ABCs, respectively [15, 16]. In our patient,
plasma and cyst fluid VEGF levels were determined by
enzyme-linked immunosorbent assay and found to be
elevated (1.12 and 16.5 ng/ml, respectively; in-house control
series of 23 healthy women: plasma average=0.166 ng/ml,
range=0.028–0.966 ng/ml).
This strategy facilitated near-complete resection of the
ABC by limiting intraoperative blood loss. However,
clinical heart failure developed in our patient, prompting
the discontinuation of bevacizumab. This was followed
by a rapid regrowth of the pelvic lesion. After a total of
seven surgical sessions, the patient's condition no longer
allowed surgical interventions and it was decided to apply
radiotherapy at a total dose of 39 Gy. Unexpectedly, at this
time, radiographical treatment evaluation showed previ-
ously undiscovered lesions in both lungs and in the left
kidney. Widespread metastatic behavior of this until then
judged benign bone neoplasm was suspected, while
differential diagnosis included secondary ABC in a yet
unidentified primary bone malignancy, malignant trans-
formation of ABC, misdiagnosed GCT, or telangiectatic
osteosarcoma. The patient's condition no longer allowed
any treatment and she died 2 years after ABC was first
diagnosed. At autopsy, metastases were found in both
lungs, both kidneys, and the liver.
Materials and methods
Pathology
Formalin-fixed paraffin-embedded specimens were avail-
able from all resections of the primary tumor. Sections
from all samples were stained by the hematoxylin and Fig. 1 Magnetic resonance image of the pelvis on admission showing
a large ABC of the left ilium
Fig. 2 a Photomicrograph of material from the first excision
(hematoxylin and eosin, ×50) showing a blood-filled cavity and solid
component containing strands of woven bone with interspersed
fibroblasts. b Photomicrograph of the lung lesion removed at autopsy.
A low-powered (hematoxylin and eosin, ×50) and high-powered
(inset, hematoxylin and eosin, ×200) view show that no blood-filled
cystic cavities were found at this site; the lesion only resembled the
solid parts of the pelvic location
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by multiple expert pathologists (PS, JB, and independent
multidisciplinary revision by the Netherlands Committee
on Bone Tumors).
Image cytometry
Three samples (two were obtained from the primary
tumor at referral to our hospital and during the last
resection, respectively, and the third was a pulmonary
metastasis obtained during autopsy) were selected for
DNA quantification by image cytometry. At least two
50-µm-thick sections were obtained of each sample
followed by a 4-μm hematoxylin and eosin section to
check for representativeness. An adaptation of the
method described by Hedley [17] was used for cell
nuclei extraction from the sections. The obtained suspen-
sions were filtered with a Partec 50-μm CellTrics filter
(Partec, Münster, Germany) and prepared into a monolay-
er by cytospin. Nuclei were stained with Feulgen's stain
and periodic acid Schiff. The samples were evaluated
using a cytometric image analysis system (QPATH, Leica
Imaging Systems, Cambridge, UK) that consists of an
automated microscope with a digital camera connected to
a computer that runs DNA analysis software. Of each
specimen, 5,000 nuclei were scanned and a minimum of
2,000 images of tumor cell nuclei were manually selected
avoiding debris, necrotic or cut cells, and cell clusters.
Lymphocytes were used as the standard internal controls.
Histogram quality was evaluated by integrated optical
density (IOD) values and its coefficient of variation (CV);
15≤IOD≤25 and CV≤5% were considered acceptable.
Criteria for ploidy classification were taken from the
guidelines of the European Society for Analytical Cellular
Pathology [18].
Fluorescence in situ hybridization
Fluorescence in situ hybridization (FISH) was performed
on the lung metastasis using BAC probes flanking the
USP6 gene, largely as described [19].
Results
Histological examination of material obtained from the
primary tumor in the pelvis during the first surgical
procedure showed a multicystic lesion with blood-filled
spaces (Fig. 2a). The septa consisted of fibroblasts which
showed no cytological features of malignancy such as
nuclear atypia or an increased number of mitoses. Inter-
spersed were woven bone fragments. No evidence of an
underlying primary lesion causing secondary ABC, neither
of evident malignant transformation of ABC, GCT, nor
telangiectatic osteosarcoma was found. The morphology of
the primary lesion was thus consistent with a primary ABC.
The other excision specimens subsequently obtained from
this pelvic tumor showed similar histology. The lung lesion
resembled the solid parts of the pelvic location; no blood-
filled cystic spaces were found here (Fig. 2b). Again, no
cytological features of malignancy were found. The three
samples (two obtained from the primary tumor and one
pulmonary lesion) that were evaluated for DNA content
were diploid. FISH performed on the pulmonary lesion
showed a break in the USP6 gene in up to 43% of the
nuclei: 24% of the nuclei showed segregation of the signal
in addition to two normal (colocalization) chromosomes 17
(Fig. 3, left panel), 15% of the nuclei showed two normal
chromosomes 17 and a single red signal (Fig. 3, middle
panel), 4% showed one colocalization and one segregation
of the signal (Fig. 3, right panel).
Fig. 3 FISH images of the lung lesion removed at autopsy using BAC
probes flanking the USP6 gene showing segregation of the signal and
colocalization of two normal chromosomes 17 (left panel), two normal
chromosomes 17 and a single red signal (middle panel), and one
colocalization and one segregation of the signal (right panel)
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Since the discovery of recurrent chromosomal abnormali-
ties, of which t(16;17)(q22;p13) is the most frequent [3–
13], primary ABC is no longer considered a reactive lesion
but rather a true benign neoplasm [1]. The t(16;17)
translocation was later shown to relocate the promoter of
CDH11, a gene that is strongly expressed in bone, in front
of the USP6 gene (TRE2, TRE17) [8]. Over the past few
years, a series of different translocations has been described
in ABC [8, 13], all resulting in oncogenic activation of the
USP6 gene on chromosome 17p13. Thus, the pathogenesis
of most primary ABCs involves upregulation of USP6
transcription driven by other highly active promoters [20].
The mechanism by which USP6 upregulation causes ABC
formation has not yet been elucidated. USP6 rearrange-
ments were shown to be restricted to the spindle cells and
were absent in the multinucleated giant cells, inflammatory
cells, endothelial cells, and osteoblasts [8]. This suggests
that the neoplastic spindle cells induce a vigorous, reactive
host response mimicking young granulation tissue, explain-
ing why for a long time the lesions were regarded reactive
[8]. The majority of ABC patients are treated by local
curettage combined with intraoperative adjuvant therapy
(e.g., cryosurgery or phenol application) with local control
rates as high as 70–90%. Almost all cases of recurrence can
be treated by re-resection [1].
To our knowledge, there are no previous reports of
metastatic behavior of primary ABC. Therefore, we consid-
ered the possibility of secondary ABC in a yet unidentified
primary bone malignancy, malignant transformation of ABC,
misdiagnosed GCT, or telangiectatic osteosarcoma. ABC-like
areas can be seen in association with GCT, occasionally
overgrowing the underlying primary tumor, and ABC can
contain solid areas strongly resembling GCT [21]. In contrast
with ABC, GCT may metastasize in 2–3% of cases,
particularly to the lungs. The diploid DNA content we found
cannot exclude GCT with metastatic potential [22, 23].
However, while chromosome 16 and 17 abnormalities have
been found infrequently in GCT [24–26], the t(16;17)(q22;
p13) translocation [8, 27] and USP6 upregulation [8]a r e
absent in reported cases. We also tested three GCTs and
could not detect a USP6 rearrangement (data not shown).
Thus, it seems highly unlikely that our case represented
metastasizing GCT of bone. Moreover, the USP6 rearrange-
ment was demonstrated in the lung metastasis, indicating
that, even if from the beginning it had been ABC secondary
to and totally overgrowing an underlying primary bone
lesion such as GCT, it is the ABC part that metastasized.
Moreover, USP6 rearrangements have not been found in
secondary ABC so far [19].
Telangiectatic osteosarcoma and ABC can be radiolog-
ically identical and histologically very difficult to distin-
guish [28–30]. Nuclear atypia and an increased number of
mitoses favor telangiectatic osteosarcoma. As an additional
diagnostic tool, several reports have suggested the use of
DNA cytometry to distinguish these entities. Whereas
ABCs are known for diploid DNA content, telangiectatic
osteosarcomas show complex karyotypes and numerous
gains and losses [31–33]. Moreover, in ABC, CDH11-
USP6 fusions as well as USP6 upregulation are pathogno-
monic, while they are absent in osteosarcoma [8, 9]. So, the
diploid nature of the lesion in our case, both in primary as
well as metastatic deposits, adequately rules out telangiec-
tatic osteosarcoma as an alternative diagnosis.
In summary, in our patient, all histological samples
obtained over a 2-year period were consistent with ABC
while lacking cytological features of malignancy. Absence
of malignant transformation was supported by DNA
content analysis: three selected samples including a
pulmonary metastasis all had diploid DNA content. Finally,
we found a rearrangement of the USP6 gene by FISH in
43% of nuclei in the pulmonary lesion, which is within the
highly variable range of positive cells (7–82%) reported for
ABC [19].We ruled out sarcomatous transformation or
GCT as cause of the metastatic behavior and confirmed the
diagnosis of ABC by our FISH data.
It can be hypothesized that the numerous surgical and
interventional radiological manipulations that were necessary
in our patient have facilitated the hematogenous spread of
ABC cell clusters. Furthermore, though bevacizumab proved
successful in reducing bleeding tendency, recent reports about
antiangiogenic therapy-induced malignant progression of
tumors to increased invasion and accelerated metastasis raise
concern about a similar effect in our patient.
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